Phase I Study of Simmitecan Hydrochloride for Injection in Patients With Advanced Solid Tumor Tolerability and Pharmacokinetics

Trial Profile

Phase I Study of Simmitecan Hydrochloride for Injection in Patients With Advanced Solid Tumor Tolerability and Pharmacokinetics

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Dec 2016

At a glance

  • Drugs Simmitecan (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors ShangHai HaiHe Pharmaceutical
  • Most Recent Events

    • 18 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 21 Oct 2016 Planned End Date changed from 1 Sep 2016 to 1 Jan 2017.
    • 18 Mar 2016 Planned End Date changed from 1 Jun 2014 to 1 Sep 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top